ARK Genomic Revolution ETF
ARKG
ARKG
319 hedge funds and large institutions have $750M invested in ARK Genomic Revolution ETF in 2022 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 62 increasing their positions, 131 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more call options, than puts
Call options by funds: $63M | Put options by funds: $62.9M
2.39% less ownership
Funds ownership: 29.85% → 27.45% (-2.4%)
53% less repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 131
Holders
319
Holding in Top 10
2
Calls
$63M
Puts
$62.9M
Top Buyers
| 1 | +$33.5M | |
| 2 | +$23.1M | |
| 3 | +$11.9M | |
| 4 |
Chevy Chase Trust
Bethesda,
Maryland
|
+$3.45M |
| 5 |
Jane Street
New York
|
+$3.39M |
Top Sellers
| 1 | -$43.6M | |
| 2 | -$38.7M | |
| 3 | -$19.1M | |
| 4 |
Rockefeller Capital Management
New York
|
-$9.44M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$8.1M |